ABSTRACT. Rates of protein turnover were measured in 19 infants during the first few days of life while they were receiving i.v. glucose. The technique consisted of a continuous i.v. infusion of L-(1-'"]leucine to measure whole body leucine flux and determination of total urinary nitrogen excretion to assess leucine oxidation rates. Subsequent to each of the studies, the decision to start total parenteral nutrition (TPN) was made by the clinician concerned, with the result that seven infants did not start TPN and 12 did. There were significantly greater urinary nitrogen excretion ( p < 0.001) and lower rates of whole body protein synthesis ( p = 0.024) and breakdown ( p = 0.015) in those who did start TPN compared with those who did not. The marked difference in nitrogen excretion between the two groups suggests that this could be a useful determinant for deciding which neonate should start TPN. (Pediatr Res 30: 418-422,1991) Abbreviations TPN, total parenteral nutrition LBWN, low birth weight neonate N, nitrogen TBUN, total body urea nitrogen urine and, therefore, is noninvasive. With this method, the calculation of whole body protein turnover involves quantifying N kinetics per se. The alternative is to use a selected "representative" amino acid labeled with a stable isotope and, by measuring dilution of this tracer, to derive values for the metabolic turnover of that particular amino acid (7). L-[1-I3C]leucine is one such tracer that has been used to measure protein turnover in premature infants (8). This method is more invasive, in that blood samples are generally used, but in the study presented here this was possible because the infants had indwelling arterial catheters. However, a further restriction is the need for breath C 0 2 collection to assess leucine oxidation. We have therefore modified the constant infusion of [l-13C]leucine method for measuring whole body protein turnover rates by using N excretion to assess leucine oxidation. The results show differences between those infants who subsequently did or did not start TPN.
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MATERIALS AND METHODS
Patients. Nineteen infants, gestational ages 30.4 + 1.2 wk (mean k SD) and weight 1.48 + 0.30 kg, were studied between 17 and 9 1 h postnatal age (46 & 17 h). Infants were studied only if they had an i.v. cannula in situ; all were given i.v. glucose and had similar energy intakes. None were enterally fed at the time of study. Only male infants were studied because of the need for accurate urine collection. Exclusion criteria were the presence of any metabolic disorders. renal failure. and insulin administraThe decision to start TPN in the sick LBWN is usually made on clinical grounds as well as objective parameters such as metabolic or nutritional status. Although it is undeniable that this group of infants requires adequate and appropriate nutrition for optimal development (I), the immaturity of their metabolic pathways (2) may limit tolerance to the solutions used in TPN. Some of these problems, such as acidosis (3) and hyperammonemia (4), have diminished because protein hydrolysates have been replaced by crystalline amino acid solutions. It is, nonetheless, prudent to consider with care the administration of TPN in the early postnatal days. One approach that could be used to recognize LBWN at particular nutritional risk would be to identify those who are becoming increasingly catabolic.
The purpose of this study was to collect values for rates of protein turnover from LBWN receiving i.v. glucose in the early postnatal period before the decision was made as to whether these neonates should start TPN. There have been few studies of whole body protein turnover in the newborn, and these have produced a wide range of values, ranging from 5 to 26 g/kg/d for protein synthesis (5, 6) . Most of the studies have used [I5N] glycine, because this procedure requires measurements only on tion. Informed parental 'consent was obtained in all cases, and the study had the approval of the local ethics committee. The clinical characteristics of all infants are listed in Table 1 . The infants were of appropriate birth weight for gestational age (9) except for cases 4, 7, and 17. All required varying degrees of ventilatory support for respiratory distress. Subsequently, seven infants were not started on TPN (group A) and 12 did start TPN (group B). The decision to start TPN was made independently by the clinician concerned, so the researcher was not involved. There was a clinical assessment of the duration of time that intensive care support would be required, which included whether a particular neonate was likely, because of the severity of the illness, to tolerate suficient enteral feeds to provide adequate nutrition. A trial of enteral feeding was given when the infant was stable and it was considered appropriate.
Stable isotope administration and nitrogen balance. The infants were given a 6-h i.v. infusion of [l-'3C]leucine at a dose of 6.1 pmol/kg/h, preceded by a priming dose of 15.3 pmol/kg. Priming the infusion reduces the time taken to achieve plateau to a maximum of 2 h in adults (10) . Heparinized blood samples (0.5 mL) were collected at 0, 2, 4, and 6 h from indwelling arterial lines and immediately separated by centrifugation, and the plasma was stored at -20°C until analysis. A tinled urine collection of about 12 h duration was started at the beginning of the infusion, using a closed circuit driven by a constant air pump, a modification of a method described previously (1 1). This enabled air to be continually blown into the urine bag, preventing development of a vacuum, while the urine was sucked into a dependent syringe outside the incubator. A further 0.2 mL of blood was taken at 0 and 12 h for plasma urea concentration measurements, to correct N excretion values for any change in TBUN during the urine collection (12) .
Laboratory analyses. I3C enrichment was measured with a VG 12-250 gas chromatograph-mass spectrometer (VG Masslab, Manchester, UK) after conversion to the tertiarybutyldimethylsilyl derivative. The ion peaks measured were m/e 302 and 303. The total N content of urine was determined by the Kjeldahl method (13) . Plasma urea measurements were made using a urease method on a Boehringer Mannhiem Hitachi 717 (Lewes, East Sussex, UK). Calculation of whole body turnover rates. The basic principles have been described previously (7) . The plasma free amino acid pool is assumed to be in continuous and instantaneous equilibrium with the intracellular pool, which together compose a single homogenous pool exchanging with body protein. Leucine enters the pool from the diet (I) and from the degradation of whole body protein (D) and leucine exit is by protein synthesis (S) and leucine oxidation (0). Therefore, in the steady state, where Q is the total turnover rate of the free leucine pool, termed the leucine flux (7). Q is calculated from the isotopic enrichment of the free leucine in plasma after a plateau value (Ep, atom % excess) has been reached.
where i is the L-[l-'3C]leucine infusion rate (pmol/kg/h) and Ei is the enrichment of L-[l-13C]leucine infused (atom % excess). Dietary intake in these infants being nil, the values for flux equal those for protein breakdown. Leucine oxidation rates were calculated, indirectly, from measurements of total urinary N (corrected as described below). The ratio of leucine oxidized to total N in the urine was assumed to be the same as the proportion of leucine in body protein N; a value of 3.8 17 mmol/g N was used for the latter, an average derived from a variety of animals and different tissues (1 4).
Correction of N excretion for any change in TBUN.
Any change in the TBUN (GTBUN) occurring during the urine collection period was added to the amount of measured N excretion and was calculated as follows:
where U 1 and U2 are plasma urea concentrations (mg NIL) at the beginning and end of the urine collection, respectively; TBW is total body water, which was calculated by assuming the body composition of LBWN at this gestational age to be 80% water (15); and 0.92 is the factor to correct for plasma containing 92% water.
Statistical analysis.
Values are given as mean & SD, and the analysis was performed by t test (two-tailed).
RESULTS
There was no difference in gestational age, birth weight, and postnatal age between groups A and B (Table 1) . Infants in group B were judged to be clinically "sicker" than those in group A. This was confirmed subsequently; for example, the mean duration of ventilation for group A was 33 h (range 0 to 4 d) and for group B, 13.3 d (1 to 47 d) and enteral feeding was started on d 5 k 1 for group A and 13 + 10 for group B. One infant (no. 16) died.
Although the weight change between the two groups was not significantly different, there was considerable variation between individuals. The large shifts in water volume in the newborn, particularly the premature, may obscure interpretation of this variable (16) . In contrast, urinary N excretion was significantly greater ( p < 0.001) in group B than in group A. Correction of this value for any change in TBUN during the urine collection resulted in an average difference in excretory N production of 1.5 mg/kg/h ( the difference between 2-and 6-h values, expressed as a percentage of their mean) was 4.9 and 2.8%. The values for leucine oxidation, protein synthesis, and protein breakdown are shown in Table 3 . In both groups, the results for protein synthesis rates were lower than those for protein breakdown because balance was negative, but less so in group A compared with group B.
Rates for both protein synthesis and breakdown were significantly higher in group A compared with group B ( p = 0.024 and 
DISCUSSION
This study has demonstrated that LBWN who were subsequently given nutritional support had lower rates of whole body protein turnover and higher N excretion than those who did not. To measure rates of whole body protein turnover, we chose to use a primed, constant infusion of [1-"C]leucine. The alternative method, administration of ["Nlglycine, has been criticized because I ) there is the possibility that glycine is an indispensible amino acid in the rapidly growing preterm infant (17) and 2) there is a substantial amount of urea in mothers' breast milk (18) . When [l-'3C]leucine is used, one problem is the necessity of measuring leucine oxidation rates to assess the contributions of oxidation and protein synthesis to whole body leucine turnover. This has generally been calculated by measuring the rate of production of labeled C02, which must include a value for the proportion of retained, labeled C02. This is greater in infants than in adults (1 9) and may alter with food intake (20) , and acidbase balance, frequently changing in LBWN, could alter COz retention. Therefore, recovery rates for C 0 2 should be determined rather than assumed (2 l), but this measurement is subject to considerable error. In addition, accurate collection of expired C 0 2 in a ventilated premature infant requires an airtight seal, which might obstruct access to the sick infant.
In a previous study of protein turnover in premature infants using [l-l"]leucine (8), leucine oxidation rates, calculated directly by measuring "C02 production rates, correlated well with indirect assessments from simultaneous N excretion measurements. It should, therefore, be possible to dispense with the calculation of ieucine oxidation rates from I3CO2 production if simultaneous measurements of N excretion were performed, and, in view of the short time of the urine collection, appropriate correction for the change in TBUN should be made. Therefore, for both practical and theoretical reasons, we chose to use this approach, which was found to be readily applicable in the setting of neonatal intensive care.
The mean value for protein synthesis in this group of 19 infants was 128 pmol/kg/h, which, assuming that leucine comprises 8% of whole body protein by weight (14) , corresponds to 5 g protein/kg/d. Even allowing for the fact that values for the healthier infants (group A) were higher than those for group B (6.5 and 4.2 g protein/kg/d, respectively), the rates are lower than others reported for premature infants. The other study that used [l-13C]leucine reported a mean value for protein synthesis of 1 1.5 g/kg/d (8) , but this was for healthy, growing, premature infants receiving breast or bottle feeds, whereas the infants in the study presented here received only glucose. Similar high rates were obtained in fed preterm infants, studied with ["Nlglycine, when values of 10.9, 1 1.2, and 13.5 g/kg/d have been reported (17, 22, 23) . A further study in parenterally fed preterm infants with [i5N]glycine reported a mean value of 8.8 g/kg/d (24) . The same group studied infants sequentially, first when fed parenterally and then enterally, and found that protein synthesis rates were 40% higher with enteral feeding (25) . By contrast, very high rates for protein synthesis, 26 g/kg/d, were reported in one study with [15N]glycine (6) , but this has been criticized for methodologic reasons (17) . These data suggest that the lower rates obtained in the study presented here result from the lack of dietary protein, and lack of enteral feeding may have contributed. This is consistent with the reduction in rates of tissue protein synthesis that occurs when young rats are starved or are given a proteinfree diet (26) .
It is interesting to consider the possible etiology of the differences found between our two groups of infants. Although it has been shown that rates of protein synthesis in rat fetuses change during the course of pregnancy (27, 28) , there were no significant differences between our groups of neonates in gestational or postnatal ages to explain the different results. Other factors include infection (29) and trauma (30) , which have been shown to increase synthesis and breakdown rates, but if these two factors had been operative one would expect the converse of what we found; namely, lower rates in the clinically sicker neonates. Those in group B were subject to more trauma, although unquantifiable, in that they received more intensive care procedures. Moreover, infection, although difficult to diagnose in neonates, was not detected. The most likely explanation of the difference between groups, however, is nutritional status. Malnutrition and lack of growth is associated with reduced rates of protein synthesis and breakdown in infants (31) . It is probable, therefore, that these neonates differed in their intrauterine nutritional status and that group B had been growing more slowly. However, separation of the infants into weight groups for gestational age (appropriate or small) did not confirm this, which may only reflect the crude nature of the subdivision. Lower rates of protein synthesis have been found in small-for-gestational-age preterm infants, when compared with normally grown ones, but this was attributed to the significantly greater gestational age of the former (32) .
The lower rates of turnover in group B neonates would result in a concomitant reduction in energy needs. This may be important for the stressed, sick, premature infant unable to tolerate as much energy in the form of glucose and fat or sufficient protein compared with their more healthy counterparts in the early postnatal days of life.
The differences in turnover rates between the two groups suggest that parameters of protein metabolism could be of use in assessing those infants in need of supplemental nutritional support by highlighting those infants who can be satisfactorily maintained on i.v. glucose alone until establishment of full enteral feeds, a process that may take several days in LBWN. There was little overlap between the groups in whole body protein synthesis rates. There was an even clearer separation of groups in the N excretion data, but only when appropriate correction was made for urea retention in the body water compartment. We would, therefore, suggest that the corrected rate of N excretion, in particular, could be useful in determining whether or not to start an individual neonate on TPN. Further studies are required to assess whether rates of protein metabolism have any predictive value for outcome.
